CRDL
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Cardiol Therapeutics reaches its Phase 3 MAVERIC enrollment target ahead of schedule and expands the pivotal trial to strengthen the efficacy assessment of CardiolRxSep 23, 2026
- Cardiol Therapeutics published Phase 2 recurrent pericarditis data in the Journal of the American Heart AssociationJul 14, 2026
- Cardiol Therapeutics expanded its U.S. Phase III MAVERIC trial network to support growing interest in the pivotal programApr 28, 2026
- Cardiol Therapeutics achieved 50% patient enrollment in Phase III MAVERIC trialJan 13, 2026
- New data from Phase II ARCHER trial demonstrate CardiolRx™ improves heart structure in acute myocarditis patients, supporting expansion across inflammatory cardiac conditionsDec 1, 2025